Diabetes Statistics in America: Nearly Half of the Population Affected by Diabetes or Prediabetes — Researchers Reveal Early Treatment Strategies for Diabetics and Lifestyle Recommendations for Those at Risk of Kidney Disease

In the ongoing battle against diabetes, a recent study conducted by researchers at the University of Bristol has uncovered a promising pathway for early intervention in kidney disease among diabetic individuals. Published in the prestigious journal Diabetes and generously supported by Kidney Research UK, this research introduces a novel mechanism through which a vital hormone safeguards renal blood vessels from the deleterious effects of diabetes.


Click here for Sugar Defender Supplements

The Diabetes Epidemic: A Growing Concern:

Diabetes, rampant and relentless, has emerged as a leading cause of kidney failure in the UK. Rooted in either insufficient insulin production by the pancreas or the body’s impaired ability to utilize insulin effectively, this chronic condition exacts a significant toll. In 2023 alone, the NHS expended a staggering £1.05 billion on dialysis and £293 million on kidney transplant surgeries, underscoring the urgency of addressing this burgeoning health crisis.

Unraveling the Underlying Mechanisms:

At the heart of diabetes-induced kidney damage lies the disruption of the glycocalyx — a fragile, gel-like lining enveloping the blood vessel surfaces within the renal domain. Prolonged elevation of blood sugar levels precipitates glycocalyx disruption, heralded by the presence of albumin in urine, a telltale sign of renal impairment.

A Novel Therapeutic Frontier:

Venturing into the intricate realm of diabetic kidney disease (DKD), researchers explored the therapeutic potential of adiponectin — a hormone secreted by adipocytes, crucial for enhancing sugar utilization, quelling inflammation, and fortifying blood vessels against damage. The groundbreaking revelation of adiponectin’s efficacy in ameliorating glycocalyx disruption, augmenting its thickness, and mitigating vascular permeability represents a paradigm shift in our understanding of renal pathophysiology.

Pioneering Perspectives:

Dr. Rebecca Foster, an esteemed associate professor of microvascular medicine at Bristol Medical School, extols this innovative therapeutic avenue as a departure from conventional wisdom. She asserts, “This marks a groundbreaking revelation, showcasing adiponectin’s pivotal role in glycocalyx maintenance.”

A Glimmer of Hope:

Drawing from their findings, researchers propose that interventions targeting the adiponectin signaling pathway hold immense promise in preserving glycocalyx integrity among diabetic cohorts, potentially thwarting the onset of DKD in this vulnerable demographic.

A Call to Action:

Dr. Aisling McMahon, the erudite executive director overseeing research and policy at Kidney Research UK, views these revelations as a beacon of hope for the diabetes-afflicted populace. She emphasizes, “The tantalizing prospect of harnessing the adiponectin pathway for DKD prevention presents an unprecedented therapeutic frontier, offering a ray of hope in our quest to combat this relentless disease.”

In conclusion, as diabetes continues its relentless advance, we must unite in our efforts to explore innovative solutions and interventions. With unwavering determination and collaborative research endeavors, we can aspire towards a future where the ravages of diabetes-induced kidney disease are mitigated, and the burden of suffering alleviated.

Diabetes: A Growing Epidemic:

The scourge of diabetes is spreading with alarming rapidity across the United States, as per the latest findings from the Centers for Disease Control (CDC). The 2022 National Diabetes Statistics Report paints a grim picture, estimating a staggering 37.3 million cases of diabetes in the country.

Prevalence and Impact:

  • Total Affected: Diabetes afflicts approximately 11.3% of the U.S. populace, encompassing both diagnosed (28.7 million) and undiagnosed cases (8.6 million).
  • Demographic Impact: Diabetes transcends socio-economic and ethnic boundaries, affecting individuals from all walks of life.
  • Prediabetes: A concerning 26.4 million individuals aged 65 or older are grappling with prediabetes, constituting nearly half of this demographic.

Incidence and Age Distribution:

  • Pediatric Cases: In 2019, a distressing 283,000 children and adolescents under 20 years were diagnosed with diabetes, with the majority suffering from type 1 diabetes.
  • Adult Diagnoses: Among adults, 1.6 million, or 5.7%, reported living with type 1 diabetes and relying on insulin for management.
  • Age Disparity: Incidence rates surge with age, with adults aged 45 to 64 and those over 65 facing heightened risk.

Complications and Healthcare Burden:

  • Systemic Impact: Diabetes wreaks havoc on various bodily systems, precipitating grave complications such as cardiovascular diseases, kidney failure, and vision impairment.
  • Hospitalizations: In 2018 alone, 8.25 million hospital discharges were attributed to diabetes, with a substantial proportion linked to cardiovascular ailments.
  • Emergency Visits: A staggering 17 million emergency department visits in 2018 were diabetes-related, with hypoglycemia and hyperglycemic crises accounting for a sizable portion.

Renal and Ocular Manifestations:

  • Kidney Disease: Nearly 39.2% of adults with diagnosed diabetes suffer from chronic kidney disease, with over 62,000 developing end-stage kidney disease.
  • Vision Impairment: Diabetes emerges as the leading cause of new blindness cases among adults aged 18–64, underscoring its devastating ocular consequences.

Mortality and Economic Toll:

  • Lethal Impact: Diabetes ranks as the seventh leading cause of death in the U.S., with over 83,000 fatalities directly attributable to the disease in 2017.
  • Financial Strain: The economic burden of diagnosed diabetes surged to a staggering $327 billion in 2017, encompassing both direct and indirect costs.

Insulin and Management Strategies:

  • Insulin Deficiency: Diabetes stems from the body’s inability to produce or effectively utilize insulin, essential for regulating blood sugar levels.
  • Treatment Modalities: While type 1 diabetes necessitates exogenous insulin administration for survival, type 2 diabetes management often involves lifestyle modifications, medications, and insulin therapy as needed.


As diabetes tightens its grip on the nation, concerted efforts are imperative to curb its relentless advance. With a multifaceted approach encompassing public health initiatives, education, and innovative therapies, we can strive towards a future where the specter of diabetes no longer looms large over our collective well-being.

Source: Centers for Disease Control National Diabetes Statistics Report 2022; National Institutes of Health *SEARCH for Diabetes in Youth study; Type 1 Diabetes Index.

We will be happy to hear your thoughts

Leave a reply

ezine articles